Advanced Leiomyosarcoma
5 clinical trials · Condition
◉ Watch Advanced Leiomyosarcoma
| Record | Firm | Date |
|---|---|---|
| Lurbinectedin + Doxorubicin In Leiomyosarcoma (NCT05099666) | Massachusetts General Hospital | 2022-02-04 |
| Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas (NCT03670069) | Fred Hutchinson Cancer Center | 2019-09-30 |
Track Advanced Leiomyosarcoma automatically
Every clearance here is in the API, with alerts when new ones post.